Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2023-08-04

FDA Approved: IZERVAY — Original Application (Astellas Pharma US, Inc.)

View source ↗

Summary

FDA approved IZERVAY (avacincaptad pegol) from Astellas for geographic atrophy due to age-related macular degeneration.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • IZERVAY (avacincaptad pegol)

Snippet

ORIG AP for IZERVAY (AVACINCAPTAD PEGOL)